Off-pump surgery reduces mortality, says German study
This article was originally published in Clinica
Executive Summary
Use of off-pump surgery in coronary artery bypass procedures has been shown to have particular advantages in women, according to the results of a German study. Research done at the Grosshadern (Munich) clinic has demonstrated a 42% reduction in mortality among female heart disease patients who underwent off pump coronary artery bypass. So says Aktion Meditech (www.aktion-meditech.de), a coalition of patients, doctors and medtech companies that aims to promote effective use of technology in German healthcare.
You may also be interested in...
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.